🔗 Permalink

Assignee profile:

DEUTERX, LLC

City:

Andover, Massachusetts

Country:

United States

Published Applications:

26

Last publication date:

2024-12-31

Patent Grants:

23

Last grant date:

2024-12-31

Top Inventors for applications by DEUTERX, LLC

These are the the leading inventors for applications assigned to DEUTERX, LLC:

Sheila DEWITT 15 Auburn, NH United States
Anthony W. Czarnik 8 Reno, NV United States
Vincent Jacques 5 Somerville, MA United States
Leonardus H.T. Van Der Ploeg 2 Newton, MA United States

Leonardus H. T. van der Ploeg 2 Newton, MA United States
William Perrault 1 Andover, MA United States
DEUTERIA PHARMACEUTICALS INC. 1 Andover, MA United States

Recent patent applications by DEUTERX, LLC

DEUTERX, LLC based in Andover, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-12-31 ✅ Patent 12,180,137 granted on 2024-12-31

US18652164

Chemistry; metallurgy

Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof

#2 | 2022-12-27 ✅ Patent 11,535,603 granted on 2022-12-27

US16992674

Chemistry; metallurgy

Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same

#3 | 2020-11-19 ✅ Patent 11,491,156 granted on 2022-11-08

US20200360382A1

Human necessities

3-(substituted-4-oxoquinazolin-3(4)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

#4 | 2019-10-31 ✅ Patent 11,040,925 granted on 2021-06-22

US20190330124A1

Chemistry; metallurgy

3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

#5 | 2018-09-27 ✅ Patent 10,555,946 granted on 2020-02-11

US20180271866A1

Human necessities

3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

#6 | 2018-05-03 ✅ Patent 10,189,858 granted on 2019-01-29

US20180118758A1

Chemistry; metallurgy

Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same

#7 | 2017-11-07 ✅ Patent 9,809,603 granted on 2017-11-07

US15240499

Chemistry; metallurgy

Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same

#8 | 2017-06-08 ✅ Patent 10,202,316 granted on 2019-02-12

US20170158579A1

Chemistry; metallurgy

3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

#9 | 2017-02-23 ✅ Patent 9,833,445 granted on 2017-12-05

US20170049762A1

Human necessities

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#10 | 2016-12-08 ✅ Patent 9,925,175 granted on 2018-03-27

US20160354355A1

Human necessities

Deuterium-enriched pioglitazone

#11 | 2016-11-17 ✅ Patent 10,188,639 granted on 2019-01-29

US20160331737A1

Human necessities

Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

#12 | 2016-10-27 ✅ Patent 9,732,031 granted on 2017-08-15

US20160311757A1

Chemistry; metallurgy

Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion

#13 | 2016-10-06 ✅ Patent 9,913,845 granted on 2018-03-13

US20160287590A1

Human necessities

3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

#14 | 2015-10-08 ✅ Patent 9,416,117 granted on 2016-08-16

US20150284346A1

Chemistry; metallurgy

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#15 | 2014-11-06

US20140329851A1

Chemistry; metallurgy

DEUTERIUM-ENRICHED PRASUGREL

#16 | 2014-09-25 ✅ Patent 9,290,475 granted on 2016-03-22

US20140288101A1

Chemistry; metallurgy

3-(substituted-4-oxoquinazolin-3(4)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

#17 | 2014-09-18 ✅ Patent 8,969,581 granted on 2015-03-03

US20140275180A1

Chemistry; metallurgy

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#18 | 2014-08-28

US20140243377A1

Chemistry; metallurgy

DEUTERIUM-ENRICHED PIOGLITAZONE

#19 | 2014-08-14 ✅ Patent 9,540,340 granted on 2017-01-10

US20140228382A1

Chemistry; metallurgy

3-(5-substituted-4-oxoquinazolin-3(4)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

#20 | 2014-08-07

US20140221369A1

Chemistry; metallurgy

5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME

#21 | 2014-01-16 ✅ Patent 8,735,454 granted on 2014-05-27

US20140018436A1

Chemistry; metallurgy

Deuterium-enriched bupropion

#22 | 2013-04-11 ✅ Patent 8,669,275 granted on 2014-03-11

US20130090357A1

Chemistry; metallurgy

Deuterium-enriched donepezil

#23 | 2012-10-04 ✅ Patent 9,090,585 granted on 2015-07-28

US20120252844A1

Chemistry; metallurgy

2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds

#24 | 2011-06-02 ✅ Patent 8,524,780 granted on 2013-09-03

US20110130463A1

Chemistry; metallurgy

Deuterium-enriched bupropion

#25 | 2009-03-26 ✅ Patent 8,722,710 granted on 2014-05-13

US20090082405A1

Human necessities

Deuterium-enriched pioglitazone

#26 | 2009-03-12 ✅ Patent 8,669,268 granted on 2014-03-11

US20090069369A1

Chemistry; metallurgy

Deuterium-enriched prasugrel

Also check out DeuteRx, LLC's (Andover, United States) applicant profile with 21 patent applications submitted.

AssigneeID:

52081 ⎘